Condition
Brain Lesion (General)
Total Trials
4
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Recruiting2
Unknown1
Withdrawn1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07249801Not ApplicableRecruiting
Closed-loop rTMS-EEG During Visuomotor Integration.
NCT06314607Recruiting
Genetic and Molecular Characterization of Nervous System Lesions
NCT05565690UnknownPrimary
Role of MRS in Brain Lesions
NCT01453777Not ApplicableWithdrawnPrimary
Safety and Effects of Autologous Adipose-Derived Stromal Cells in Patients With Diffuse Lesions in the Brain
Showing all 4 trials